Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue

Signal Transducer and Activator of Transcription (STAT) proteins have been identified as drivers of prostate cancer (PCa) progression and development of aggressive castration-resistant phenotypes. In particular, STAT3, 5, and 6 have been linked to resistance to androgen receptor inhibition and metas...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Celina Ebersbach, Alicia-Marie K. Beier, Pia Hönscheid, Christian Sperling, Korinna Jöhrens, Gustavo B. Baretton, Christian Thomas, Ulrich Sommer, Angelika Borkowetz, Holger H. H. Erb
Format: Article
Sprog:English
Udgivet: MDPI AG 2022-02-01
Serier:Life
Fag:
Online adgang:https://www.mdpi.com/2075-1729/12/2/240
_version_ 1827654233486262272
author Celina Ebersbach
Alicia-Marie K. Beier
Pia Hönscheid
Christian Sperling
Korinna Jöhrens
Gustavo B. Baretton
Christian Thomas
Ulrich Sommer
Angelika Borkowetz
Holger H. H. Erb
author_facet Celina Ebersbach
Alicia-Marie K. Beier
Pia Hönscheid
Christian Sperling
Korinna Jöhrens
Gustavo B. Baretton
Christian Thomas
Ulrich Sommer
Angelika Borkowetz
Holger H. H. Erb
author_sort Celina Ebersbach
collection DOAJ
description Signal Transducer and Activator of Transcription (STAT) proteins have been identified as drivers of prostate cancer (PCa) progression and development of aggressive castration-resistant phenotypes. In particular, STAT3, 5, and 6 have been linked to resistance to androgen receptor inhibition and metastasis in in vitro and in vivo models. This descriptive study aimed to validate these preclinical data in tissue obtained from patients with PCa before and while under androgen-deprivation therapy. Therefore, STAT3, 5, and 6 expressions and activity were assessed by immunohistochemistry. The data revealed that STAT3 and 5 changed in PCa. However, there was no relationship between expression and survival. Moreover, due to the heterogeneous nature of PCa, the preclinical results could not be transferred congruently to the patient’s material. A pilot study with a longitudinal patient cohort could also show this heterogeneous influence of systemic therapy on STAT3, 5, and 6 expressions and activity. Even if the main mechanisms were validated, these data demonstrate the urge for better patient-near preclinical models. Therefore, these data reflect the need for investigations of STAT proteins in a longitudinal patient cohort to identify factors responsible for the diverse influence of system therapy on STAT expression.
first_indexed 2024-03-09T21:35:30Z
format Article
id doaj.art-881d12c967dc484f93f7a32fe6c22fb7
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T21:35:30Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-881d12c967dc484f93f7a32fe6c22fb72023-11-23T20:46:17ZengMDPI AGLife2075-17292022-02-0112224010.3390/life12020240Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer TissueCelina Ebersbach0Alicia-Marie K. Beier1Pia Hönscheid2Christian Sperling3Korinna Jöhrens4Gustavo B. Baretton5Christian Thomas6Ulrich Sommer7Angelika Borkowetz8Holger H. H. Erb9Department of Urology, Technische Universität Dresden, 01307 Dresden, GermanyDepartment of Urology, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Pathology, Universitätsklinikum Carl Gustav Carus Dresden, 01307 Dresden, GermanyInstitute of Pathology, Universitätsklinikum Carl Gustav Carus Dresden, 01307 Dresden, GermanyInstitute of Pathology, Universitätsklinikum Carl Gustav Carus Dresden, 01307 Dresden, GermanyInstitute of Pathology, Universitätsklinikum Carl Gustav Carus Dresden, 01307 Dresden, GermanyDepartment of Urology, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Pathology, Universitätsklinikum Carl Gustav Carus Dresden, 01307 Dresden, GermanyDepartment of Urology, Technische Universität Dresden, 01307 Dresden, GermanyDepartment of Urology, Technische Universität Dresden, 01307 Dresden, GermanySignal Transducer and Activator of Transcription (STAT) proteins have been identified as drivers of prostate cancer (PCa) progression and development of aggressive castration-resistant phenotypes. In particular, STAT3, 5, and 6 have been linked to resistance to androgen receptor inhibition and metastasis in in vitro and in vivo models. This descriptive study aimed to validate these preclinical data in tissue obtained from patients with PCa before and while under androgen-deprivation therapy. Therefore, STAT3, 5, and 6 expressions and activity were assessed by immunohistochemistry. The data revealed that STAT3 and 5 changed in PCa. However, there was no relationship between expression and survival. Moreover, due to the heterogeneous nature of PCa, the preclinical results could not be transferred congruently to the patient’s material. A pilot study with a longitudinal patient cohort could also show this heterogeneous influence of systemic therapy on STAT3, 5, and 6 expressions and activity. Even if the main mechanisms were validated, these data demonstrate the urge for better patient-near preclinical models. Therefore, these data reflect the need for investigations of STAT proteins in a longitudinal patient cohort to identify factors responsible for the diverse influence of system therapy on STAT expression.https://www.mdpi.com/2075-1729/12/2/240STAT3STAT5STAT6androgen deprivation therapynovel hormonal therapychemotherapy
spellingShingle Celina Ebersbach
Alicia-Marie K. Beier
Pia Hönscheid
Christian Sperling
Korinna Jöhrens
Gustavo B. Baretton
Christian Thomas
Ulrich Sommer
Angelika Borkowetz
Holger H. H. Erb
Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
Life
STAT3
STAT5
STAT6
androgen deprivation therapy
novel hormonal therapy
chemotherapy
title Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
title_full Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
title_fullStr Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
title_full_unstemmed Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
title_short Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue
title_sort influence of systemic therapy on the expression and activity of selected stat proteins in prostate cancer tissue
topic STAT3
STAT5
STAT6
androgen deprivation therapy
novel hormonal therapy
chemotherapy
url https://www.mdpi.com/2075-1729/12/2/240
work_keys_str_mv AT celinaebersbach influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT aliciamariekbeier influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT piahonscheid influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT christiansperling influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT korinnajohrens influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT gustavobbaretton influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT christianthomas influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT ulrichsommer influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT angelikaborkowetz influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue
AT holgerhherb influenceofsystemictherapyontheexpressionandactivityofselectedstatproteinsinprostatecancertissue